Filing Details

Accession Number:
0000905718-19-000989
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-23 16:05:13
Reporting Period:
2019-12-19
Accepted Time:
2019-12-23 16:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1698530 Exicure Inc. XCUR Pharmaceutical Preparations (2834) 815333008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1784138 Bali Muralidhar C/O Exicure, Inc.
8045 Lamon Avenue, Suite 410
Skokie IL 60077
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $0.0001 Par Value Acquisiton 2019-12-19 727,000 $2.75 6,977,000 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. The shares are held by Abingworth Bioventures VII LP ("Abingworth VII"). Abingworth Bioventures VII GP LP ("Abingworth GP") serves as the general partner of Abingworth VII. Abingworth General Partner VII LLP, serves as the general partner of Abingworth GP. Abingworth VII (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner VII LLP) has delegated to Abingworth LLP ("ALLP"), all investment and dispositive power over the securities held by Abingworth VII. ALLP holds the reported securities indirectly through Abingworth VII. The reporting person is an employee of ALLP.
  2. The reporting person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.